GenHealth.ai
Markets
Use Cases
Products
Company
Docs
Get a Demo
Automated Prior Authorization
with Generative AI. See how we support health plans and providers with prior auth.
Generative AI Healthcare Analytics
Use natural language to ask any question of your data: past, present, and future.
Search all medical codes
D47.1
Chronic myeloproliferative disease
ICD10CM code
Medical Policies and Guidelines for Chronic myeloproliferative disease
Related policies from health plans
ANTHEM-BLUECROSS-CA
Gene Mutation Testing for Solid Tumor Cancer Susceptibility and Management
CIGNA
Flow Cytometry - (0538)
ANTHEM-BLUECROSS-CA
Vidaza (Azacitidine)
ANTHEM-BLUECROSS-CT
CG-GENE-14 Gene Mutation Testing for Cancer Susceptibility and Management
ANTHEM-BLUECROSS-CT
TRANS.00024 Hematopoietic Stem Cell Transplantation for Select Leukemias and Myelodysplastic Syndrome
ANTHEM-BLUECROSS-CT
TRANS.00024 Hematopoietic Stem Cell Transplantation for Select Leukemias and Myelodysplastic Syndrome
SUNFLOWER
Concert Genetic Oncology: Cytogenetic Testing (PDF)
SUNFLOWER
Concert Genetic Oncology: Mol Analysis Solid Tmrs Hem Malig (PDF)
SUNFLOWER
Concert Genetic Oncology: Mol Analysis Solid Tmrs Hem Malig (PDF)
Similar Codes
ICD10CM codes
D47.1
- Chronic myeloproliferative disease
C93.1
- Chronic myelomonocytic leukemia
D61.82
- Myelophthisis
D46
- Myelodysplastic syndromes
D46.9
- Myelodysplastic syndrome, unspecified
D46.79
- Other myelodysplastic syndromes
C90.0
- Multiple myeloma
D75.81
- Myelofibrosis
D46.Z
- Other myelodysplastic syndromes
C88.7
- Other malignant immunoproliferative diseases
HCPCS codes
G9842
- Patient has metastatic disease at diagnosis
G9266
- Patient receiving maintenance hemodialysis for greater than or equal to 90 days without a catheter a
G8972
- One or more high risk factors for thromboembolism or more than one moderate risk factor for thromboe
J0887
- Injection, epoetin beta, 1 microgram, (for esrd on dialysis)
P9100
- Pathogen(s) test for platelets
G8082
- End stage renal disease patient requiring hemodialysis documented to have received vascular access o
P9021
- Red blood cells, each unit
Q2043
- Sipuleucel-t, minimum of 50 million autologous cd54+ cells activated with pap-gm-csf, including leuk
G9223
- Pneumocystis jiroveci pneumonia prophylaxis prescribed within 3 months of low cd4+ cell count below
A9507
- Indium in-111 capromab pendetide, diagnostic, per study dose, up to 10 millicuries
CPT4 codes
81339
- MPL (MPL proto-oncogene, thrombopoietin receptor) (eg, myeloproliferative disorder) gene analysis; s
81338
- MPL (MPL proto-oncogene, thrombopoietin receptor) (eg, myeloproliferative disorder) gene analysis; c
81219
- CALR (calreticulin) (eg, myeloproliferative disorders), gene analysis, common variants in exon 9
0027U
- JAK2 (Janus kinase 2) (eg, myeloproliferative disorder) gene analysis, targeted sequence analysis ex
81270
- JAK2 (Janus kinase 2) (eg, myeloproliferative disorder) gene analysis, p.Val617Phe (V617F) variant
88237
- Tissue culture for neoplastic disorders; bone marrow, blood cells
81279
- JAK2 (Janus kinase 2) (eg, myeloproliferative disorder) targeted sequence analysis (eg, exons 12 and
81305
- MYD88 (myeloid differentiation primary response 88) (eg, Waldenstrom's macroglobulinemia, lymphoplas
38221
- Diagnostic bone marrow; biopsy(ies)
85660
- Sickling of RBC, reduction